Context Therapeutics Inc.
CNTX
$0.8595
-$0.0134-1.54%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -291.55% | -24.80% | 50.62% | -197.20% | 55.01% |
Total Depreciation and Amortization | 57.69% | 57.69% | 11.54% | -9.68% | -18.75% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 164.84% | 33.21% | 0.39% | 5,606.48% | -48.61% |
Change in Net Operating Assets | 304.01% | 17.16% | -154.77% | -74.67% | -1,863.50% |
Cash from Operations | -73.88% | -15.31% | 32.11% | 44.14% | 27.54% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -100.00% | -- | -- | -- | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -106.38% | -16.44% | 233.22% | -383.55% | 2,074.64% |